Typically, TNBC patients contain higher mutations and more pronounced immune cell infiltration than other breast cancers (Dieci, Miglietta & Guarneri, 2021), and over 20% of TNBC patients showed upregulation of PD-L1 (Oner et al., 2021). This evidence concerns the gene CD274 and breast cancer.